REFERENCES
- Bigwood , J. , Ott , J. , Thompson , C. and Neely , P. 1979 . Entheogenic effects of ergonovine . Journal of Psychedelic Drugs , Vol. 11 ( 1–2 ) : 147 – 149 .
- Douglas , W. W. 1980 . “ Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. ” . In The Pharmacological Basis of Therapeutics., , 6th ed. Edited by: Gilman , A. G. , Goodman , L. S. and Gilman , A. New York : Macmillan. .
- Graham , J. 1967 . Cardiac and pulmonary fibrosis during methysergide therapy for headache . American Journal of Medical Science , Vol. 254 : 1 – 12 .
- Hoffer , A. and Osmond , H. 1967 . The Hallucinogens. New York : Academic Press. .
- Levine , R. J. 1974 . “ Serotonin and the carcinoid syndrome; histamine and mastocytosis. ” . In Duncan's Diseases of Metabolism: The Genetic and Biochemical Basis of Disease., , 7th ed. Edited by: Bondy , P. K. and Rosenberg , L. E. Vol. 2 , Philadelphia : W.B. Saunders. .
- Medical Economics . 1986 . Physicians' Desk Reference., , 40th ed. Oradell , New Jersey : Medical Economics. .
- Ott , J. and Neely , P. 1980 . Entheogenic (hallucinogenic) effects of methylergonovine . Journal of Psychedelic Drugs , Vol. 12 ( 2 ) : 165 – 166 .
- Persyko , I. 1972 . Psychiatric adverse effects to methysergide . Journal of Nervous and Mental Disease , Vol. 154 ( 4 ) : 299 – 301 .
- Warner , R. 1967 . Current status and implications of serotonin in clinical medicine . Advances in Internal Medicine , Vol. 13 : 241 – 282 .